Skip to main content
PLOS One logoLink to PLOS One
. 2024 Jan 19;19(1):e0296319. doi: 10.1371/journal.pone.0296319

Development of novel optical character recognition system to reduce recording time for vital signs and prescriptions: A simulation-based study

Shoko Soeno 1, Keibun Liu 2,*, Shiruku Watanabe 2, Tomohiro Sonoo 2, Tadahiro Goto 2
Editor: Asadullah Shaikh3
PMCID: PMC10798482  PMID: 38241403

Abstract

Digital advancements can reduce the burden of recording clinical information. This intra-subject experimental study compared the time and error rates for recording vital signs and prescriptions between an optical character reader (OCR) and manual typing. This study was conducted at three community hospitals and two fire departments in Japan. Thirty-eight volunteers (15 paramedics, 10 nurses, and 13 physicians) participated in the study. We prepared six sample pictures: three ambulance monitors for vital signs (normal, abnormal, and shock) and three pharmacy notebooks that provided prescriptions (two, four, or six medications). The participants recorded the data for each picture using an OCR or by manually typing on a smartphone. The outcomes were recording time and error rate defined as the number of characters with omissions or misrecognitions/misspellings of the total number of characters. Data were analyzed using paired Wilcoxon signed-rank sum and McNemar’s tests. The recording times for vital signs were similar between groups (normal state, 21 s [interquartile range (IQR), 17–26 s] for OCR vs. 23 s [IQR, 18–31 s] for manual typing). In contrast, prescription recording was faster with the OCR (e.g., six-medication list, 18 s [IQR, 14–21 s] for OCR vs. 144 s [IQR, 112–187 s] for manual typing). The OCR had fewer errors than manual typing for both vital signs and prescriptions (0/1056 [0%] vs. 14/1056 [1.32%]; p<0.001 and 30/4814 [0.62%] vs. 53/4814 [1.10%], respectively). In conclusion, the developed OCR reduced the recording time for prescriptions but not vital signs. The OCR showed lower error rates than manual typing for both vital signs and prescription data.

Introduction

Despite the evolution of clinical technologies, traditional methods of information sharing, including paper-based medical records, remain prevalent in many settings. This is particularly evident in prehospital settings, emergency departments, and disaster sites. While the advancement and widespread adoption of mobile devices have enhanced healthcare, particularly in prehospital settings [1], the handover process from prehospital care to emergency departments often depends on paper documents or manual input to smart device interfaces.

Accurately collecting essential information, including vital signs and prescription lists, as digitized data to assess a patient’s medical history is crucial for paramedics and medical staff to improve patient and research outcomes. Furthermore, information must be collected promptly because settings are often in an emergency state, thus requiring frontline paramedics and clinicians to perform multiple tasks while simultaneously gathering information. The current method of paper-based documentation or manual typing with smart devices is time consuming, which results in multiple errors during the information collection and transfer process and subsequently delays definitive treatment. Therefore, the immediate digitization of essential information to capture a scene is urgently needed.

Previous studies have explored the optical character recognition (OCR) technology used to capture vital signs from paper-based encounters or commercial devices such as oximeters and thermometers [2, 3]. A mobile app–based intelligent care system, including OCR, has the potential to reduce health-related issues in patients with chronic kidney disease [4]. However, these studies did not consider the unique conditions of prehospital settings. Such environments present distinct challenges including time constraints and the requirement for emergency medical personnel to use the system to provide treatment. Here we developed a novel OCR system to recognize the characteristics and number of vital signs on ambulance monitors and translate them into digitized data. This system had the ability to recognize the names of medications on a prescription list and link the digitized information with the names in the World Health Organization drug dictionary. The matched names were then stored as digitized data (e.g., anatomical therapeutic chemical classification codes).

This study aimed to compare the newly developed OCR with manual typing using an iPhone in terms of the time and error rate required to record vital signs on an ambulance monitor and medications on a prescription list in an experimental setting. The main targets of this system, including frontline paramedics and emergency department medical staff, were the participants.

Materials and methods

Study design and settings

This intra-participant experimental study was conducted from October to December 2021 at the emergency medicine departments of three community hospitals (Hitachi General Hospital, Takasaki Medical Centre, and Southern Tohoku General Hospital) and two fire departments (Takasaki Fire Department, Takasaki, Gunma and Koriyama Fire Department, Koriyama, Fukushima) covering the hospital area. This study was approved by the Institutional Review Board (IRB) of TXP Medical Co., Ltd., which is certified by the Japanese Ministry of Health, Labour and Welfare (IRB no. 21000041; registration no. TXPREC-005).

Participants

Participants were recruited as volunteers by SS and KL with the help of the supervisory personnel of each department without any exclusion criteria. We collected the participants’ characteristics such as age, sex, length of work experience since graduation, emergency medicine board certification status, and type of private smartphone used.

Application software

We used NEXT Stage ER mobile (NSER mobile; TXP Medical Co., Ltd., Tokyo, Japan), an application aimed at aiding paramedics and emergency physicians share clinical information between remote devices in prehospital settings [5]. The NSER mobile system was equipped with an OCR tool that recorded vital signs on an ambulance monitor and prescriptions written in a pharmacy notebook. Although not an open-source device, the OCR system is marketed as an integral component of the NEXT Stage ER mobile device by TXP Medical Co., Ltd. Therefore, it is feasible to replicate our findings using a NEXT Stage ER mobile device.

Study protocol

All participants received 30 min of instructions from the instructor (SS) on how to perform the experiment and used an NSER mobile device as described in the S1 and S2 Videos. Although hands-on feedback and additional instructions were provided during the training, no guidance was provided during the actual study. Each participant initially used the OCR system and then manually entered the same information (iPhone 12 or 13; Apple Inc., Cupertino, California). The recording flow is illustrated in Fig 1. When using the OCR tool, the participants clicked the New Registration button to start, took a picture of the vital signs monitor or prescription list using the OCR button, and clicked the Finish Recording button. While entering the data manually, the participants clicked the New Registration button, typed in the clinical information, and finished the experiment by clicking the Finish Recording button.

Fig 1. Recording flow.

Fig 1

A. Recording flow. B. Application screens. Abbreviations: OCR, optical character recognition.

We used six sample pictures: three ambulance monitors showing vital signs (categorized as normal, abnormal, or shock; S1 Fig) and three of a pharmacy notebook detailing the prescriptions (with two, four, or six medications; S2 Fig). For each picture, the participants recorded the data using OCR or manually into a smartphone. The pictures on the ambulance monitor displayed each patient’s blood pressure, pulse rate, oxygen saturation, and respiratory rate. Three sample pictures of the prescription list with two, four, or six medication names were used. The ethics committee waived the requirement for informed consent from the patients or the sources of the sample pictures because the pictures were anonymized. Each participant provided written informed consent before the experiment.

Each user’s actions on the system were automatically logged onto a cloud data server specific to this study for calculation of the recording time. The Internet speed at the site was measured during the study whenever possible.

Outcomes

The primary outcome was the recording time of vital signs or prescription list data. The recording time was defined as the duration that lapsed from the user clicking the New Registration button to clicking the Finish Recording button for the OCR and manual typing processes (Fig 1). Time was calculated using data from the automatic logs of the system. The secondary outcome was error rate defined as the ratio of omissions or typographical errors (misrecognitions for OCR or mistakes for manual typing) to the total number of characters. For example, the vital signs comprise five metrics: pulse rate, systolic blood pressure, diastolic blood pressure, partial pressure of oxygen, and respiratory rate. When a participant failed to record a respiratory rate of 18, the number of errors was two. If a participant mistakenly typed a pulse of 82 for a pulse of 72, the number of errors was one.

Statistical analysis

To calculate the sample size, we conducted a pilot study with two volunteers (senior residents). The results were as follows: for vital signs, the mean time required to record three pictures using OCR was 16.3 s (standard deviation [SD], 2.4 s), while the time required for manual typing was 22.0 s (SD, 4.6 s); for prescriptions, the mean time for recording two pictures (S2 Fig; Prescriptions A and B) using OCR was 28.8 s (SD, 9.5 s), while the time required for manual typing was 93.5 s (SD, 42.8 s). Based on these numbers, a total of 20 and 14 participants for vital signs and prescription list recording, respectively, would be sufficient to test for differences in time when using a paired t-test with a significance level of 0.05 and power of 0.9. We also conducted a post hoc analysis to ensure that the study was adequately powered. For vital signs, assuming an average input time of 30 s (SD, 10 s) for manual typing and 25 s for OCR, with a significance level (α) set at 0.05 and a power (β) of 0.80, the required sample size was 32 individuals. For prescriptions, we considered a scenario in which OCR reduces input time from an average of 100 s (SD, 30 s) to 50 s, with an α set at 0.05 and a β of 0.80, a sample size of 12 individuals was sufficient.

Categorical variables are expressed as numbers with proportions. Continuous variables are expressed as medians with interquartile ranges (IQR). Intra-person comparisons were used because the recording time of clinical information inherently involves inter-person differences. For the recording time, the Wilcoxon signed-rank test was used to assess the differences in outcomes between the OCR and manual typing groups. For the error rate, McNemar’s test was performed to compare the error rates between groups. In cases of missing data, imputation was not applied in the analysis. As we used test-ranked paired observations, comparisons were possible only when the OCR and manual typing values were available. In cases in which either pair was lacking, the data were excluded.

In the sensitivity analyses, we repeated the analysis with stratification by participant age, profession, and Internet speed at the study site.

As a sensitivity analysis, we also performed a complete case analysis in which we excluded all records of participants for whom one or more input values were missing.

The sample size was calculated using R version 4.0.3 (R Foundation, Vienna, Austria). Other analyses were performed using Stata software (version 17.0; StataCorp LP, College Station, TX, USA).

Results

Main analysis

Thirty-eight participants (15 paramedics, 10 nurses, and 13 doctors) were recruited. The median age was 34 years (IQR, 27–46 years); of them, 74% (n = 28) were men and 68% used an iPhone daily (Table 1). While we assumed 228 paired datasets (38 participants × 6 pictures), nine sets of vital sign monitors and five sets of prescriptions had no records or data errors. Fourteen paired datasets were excluded.

Table 1. Participants’ characteristics.

Variable Overall (N = 38) Physicians (n = 13) Nurses (n = 10) Paramedics (n = 15)
Age, years 34 (27–46) 32 (29–40) 26 (24–34) 37 (36–47)
Male sex 28 (74%) 10 (77%) 4 (40%) 14 (93%)
Facility
    Hitachi General Hospital 3 (8%) 3 (23%) 0 (0%) 0 (0%)
    Southern Tohoku General Hospital 10 (26%) 5 (38%) 5 (50%) 0 (0%)
    Takasaki General Medical Center 16 (42%) 5 (38%) 5 (50%) 0 (0%)
    Takasaki Fire Department 0 (0%) 0 (0%) 0 (0%) 6 (40%)
    Koriyama Fire Department 0 (0%) 0 (0%) 0 (0%) 9 (60%)
Length of experience, years 9 (5–19) 6 (4–9) 5 (2–13) 15 (12–28)
Certified emergency medicine specialista 20 (53%) 5 (38%) 0 (0%) 15 (100%)
Type of private smartphone
    iPhone 26 (68%) 9 (69%) 9 (90%) 8 (53%)
    Android 12 (32%) 4 (31%) 1 (10%) 7 (47%)

aBoard-certified emergency physician or paramedic

Values are shown as median (interquartile range) or n (%), as appropriate.

The median recording times for vital signs were similar between groups (normal state, 21 s [IQR, 17–26 s] in the OCR group vs. 23 s [IQR, 18–31 s] in the typing group; p = 0.11; S1 Table, Fig 2).

Fig 2. Recording times of optical character recognition versus manual typing (intra-person comparison, n = 38).

Fig 2

(A) Vital signs and (B) prescriptions. Abbreviations: OCR, optical character recognition.

A paired Wilcoxon signed-rank sum test was used to compare the recording times. In contrast, the median recording times for prescriptions were significantly shorter in the OCR group (e.g., six medications list, 18 s [IQR, 14–21 s] in the OCR group vs. 144 s [IQR, 112–187 s] in the manual typing group; p≤0.001; Fig 2). In addition, the error rate was significantly lower in the OCR group than in the manual typing group (for a total of three pictures of vital signs, 0/1056 [0%] in the OCR group vs. 14/1056 [1.32%] in the typing group; p<0.001) (Table 2). The error rate was lower for the OCR system than for manual typing of recorded prescriptions (30/4814 [0.62%] vs. 53/4814 [1.10%]; p<0.001) (Table 2). The characteristics of the omissions differed between groups. If the OCR failed to recognize a drug name, the remaining drug information (amount, shape, and units) was omitted. The OCR tool missed all five medications. During manual typing, participants tended to omit details, such as the shape of the medicine (e.g., tablet or capsule) and units (e.g., mg).

Table 2. Error rates.

Recording target OCR group (n = 38) Manual typing group (n = 38) P valuea
Vital signs on the monitor
    Overall 0/1056 (0%) 14/1056 (1.32%) <0.001
    Omissions 0/1056 (0%) 12/1056 (1.13%)
    Misrecognition/mistyping 0/1056 (0%) 2/1056 (0.19%)
Prescription lists
    Overall 30/4814 (0.62%) 53/4814 (1.10%) <0.001
    Omissions 30/4814 (0.62%) 46/4814 (1.10%)
    Misrecognition/mistyping 0/4814 (0%) 7/4814 (0.15%)

The error rate is defined as the rate of typographical errors or omissions evaluated by the number of misrecognitions for OCR, misspellings for manual typing, or omissions of the total number of words.

aMcNemar’s test

Age category

The input time by age category showed that participants in their 40s or older completed the input in the same amount of time as other age categories when using OCR, whereas the recording time using manual typing in this group was twice that of participants in their 20s (Fig 3).

Fig 3. Recording time by age category.

Fig 3

(A) Vital signs; and (B) Prescription. Abbreviations: OCR, optical character recognition.

Profession

With the OCR, no apparent difference was found in the input time for vital signs or prescriptions among the professionals. When using manual typing, the paramedics tended to require more time to complete the input than the doctors or nurses (S3 Fig).

Internet transmission speed

We measured the Internet transmission speed for 18 participants (14 Mbps for 13 participants and 78 Mbps for five) to investigate the OCR. The input time for vital signs and prescriptions was significantly shorter when the experiments were performed at a higher Internet transmission speed (p<0.001) (S2 Table, S4 Fig).

Sensitivity analysis

A total of 23 participants were included in the sensitivity analysis; only complete cases were used. The results of the sensitivity analysis were consistent with those of the primary analysis of input time (S3 Table).

Discussion

Our findings indicate that using the OCR system notably reduced the prescription list recording time compared with manual typing, with a dose–response relationship; however, there was no difference in the recording time of vital signs irrespective of severity. The error rate of the OCR system was lower than that of manual typing of vital signs and prescriptions. The input time with manual typing was subjective to the participants’ ages and professions, whereas the OCR was less affected or unaffected by these variables. Nevertheless, the Internet transmission speed at the study location may have affected the digitalization speed in the OCR system. To the best of our knowledge, this is the first study to examine the application of OCR to record vital signs and prescriptions.

When the OCR system was used to record vital signs on the monitor, the recording time did not change with increasing accuracy. In prehospital settings, vital signs are imperative to deciding whether patients should be transferred and the procedures necessary to stabilize them [6]. Therefore, the timely and accurate digitization and sharing of vital signs are expected to facilitate this process in prehospital and emergency room settings.

The input time of the prescription list was significantly shortened and more accurate with OCR versus manual typing. This beneficial effect is proportional to the number of medicines on the list. Polypharmacy has become a major problem in our aging society; older adults commonly take five or more medicines [7]. Prescriptions provide critical information about a patient’s medical history, particularly in cases of unconsciousness [8]. Therefore, the OCR system could aid frontline paramedics and medical staff quickly monitor several medications by researching their drug information.

The error characteristics observed in this study are noteworthy. In the OCR group, the vital signs were not misrecognized, and five medications were omitted. This may indicate that the user must check whether the number of medicines on the list matches the digitized data. The error rate was higher in the manual typing group; however, only drug information details were omitted. Errors that occur with OCR use are often attributed to the photo-resolution [9]. Introducing a system to detect and request the re-uploading of low-resolution photos can help collect training data to mitigate these errors.

Other advantages were observed in the sub-analysis. The OCR system was not affected by user age or profession, which significantly affected the input time for manual typing. These findings indicate that the OCR system can be applied regardless of user characteristics and provide consistent and reliable results. The Internet transmission speed may have influenced the OCR system performance because the captured image of the vital signs or prescription list was sent to the cloud server via the Internet. Further studies involving various types of users and different Internet transmission speeds are necessary.

Digitizing clinical information using an OCR system has several benefits. First, digitization can smooth various procedures, reduce time and cost, and improve patient outcomes. For instance, prehospital transportation time is associated with outcomes among stroke patients [10]. However, less than half of the emergency medical service response times meet United States stroke guidelines [11]. This OCR system outputs structured drug information and instantly assigns codes such as the Anatomical Therapeutic Chemical code [12]. For example, this feature allows paramedics to screen anticoagulants and generic drugs that are contraindications for thrombolytic therapy or endovascular thrombectomy. Second, medical information can be shared and accessed through the cloud. Immediate data sharing facilitates communication between paramedics and clinicians. Third, digitized data can be used in clinical research [13]. If structured data are accumulated in a database, it will become big data for use to answer various clinical questions. Compared with manual data collection, digitization potentially increases data quality and quantity, enabling the performance of novel research. Finally, this OCR technology can be applied to various other clinical settings, such as general screening at scheduled hospital admissions and during a patient’s first visit to a clinic without a medical history. OCR/natural language processing (NLP) hybrid usage significantly improves data extraction efficiency [14, 15]. Thus, the importance of OCR is likely to increase further when used in conjunction with NLP.

Our study has several limitations. First, our dataset featured missing data and outliers with a small sample size, which may have affected the interpretation of the results. However, the exclusion of cases of missing data did not affect its primary outcome (S3 Table). A larger sample size is required to validate the reliability of these results. In addition, we did not conduct repeated measurements for each participant, which may have limited the replicability of our findings. Second, only six photographs were used in the experimental setting. The effect and error rate of OCR must be verified in actual prehospital and clinical settings. Third, we used only iPhones to record the data. Fourth, recruiting participants on a volunteer basis may have caused selection bias. And finally, although a pre-calculated sample size was achieved here, the number of participants and occupations remained limited. For instance, medical clerks, who often help document medical information, did not participate in this study. As a next step, we will incorporate this technology into clinical practice, mainly in prehospital or emergency care settings, and investigate its reliability and effectiveness in future studies.

Conclusions

Using an OCR developed by machine learning with pattern recognition significantly reduced the time required to record prescription lists. Further clinical studies are warranted to confirm the effects of OCR systems on patient outcomes.

Supporting information

S1 Video. Explanatory video of the study protocol.

(MP4)

S2 Video. Explanatory video of the study protocol.

(MP4)

S1 Fig. Sample pictures of vital sign monitoring.

Panel A. Vital signs within the normal state. Panel B. Vital signs in an abnormal state. Panel C. Vital signs in the shock state.

(PDF)

S2 Fig. Sample pictures of prescriptions in pharmacy notebooks.

Prescription A (two medications; total number of characters to count for error rate calculation: 32). Prescription B (four medications; total number of characters to count for error rate calculation: 55). Prescription C (six medications; total number of characters to count for error rate calculation: 76).

(PDF)

S3 Fig. Recording time by profession.

(PDF)

S4 Fig. Recording time by Internet transmission speed (megabits per second).

(PDF)

S1 Table. Differences in recording time between the optical character recognition and manual typing groups (n = 38).

(PDF)

S2 Table. Differences in recording time by Internet transmission speed (megabits per second).

(PDF)

S3 Table. Differences in recording time between optical character recognition and manual typing and complete case analysis (n = 23).

(PDF)

Acknowledgments

We thank Dr. Hiromu Naraba, Dr. Kensuke Nakamura, and Dr. Hiroshi Machida for recruiting participants at their hospitals. We also thank the paramedics at the Takasaki and Koriyama Fire Departments for participating in this study and Mr. Keita Saegusa for creating the explanatory video.

Data Availability

Data relevant to this study are available from Dryad at https://doi.org/10.5061/dryad.fxpnvx10c.

Funding Statement

TXP Medical Co. Ltd. provided support in the form of salaries for SS, SW, TS, and TG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.

References

  • 1.Amadi-Obi A, Gilligan P, Owens N, O’Donnell C. Telemedicine in pre-hospital care: a review of telemedicine applications in the pre-hospital environment. Int J Emerg Med. 2014;7: 29. doi: 10.1186/s12245-014-0029-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Biondich PG, Overhage JM, Dexter PR, Downs SM, Lemmon L, McDonald CJ. A modern optical character recognition system in a real world clinical setting: Some accuracy and feasibility observations. Proc AMIA Symp. 2002;vv: 56–60. [PMC free article] [PubMed] [Google Scholar]
  • 3.Raposo A, Marques L, Correia R, Melo F, Valente J, Pereira T, et al. e-CoVig: a novel mhealth system for remote monitoring of symptoms in COVID-19. Sensors (Basel). 2021;21: 3397. doi: 10.3390/s21103397 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Liu W, Yu X, Wang J, Zhou T, Yu T, Chen X, et al. Improving kidney outcomes in patients with nondiabetic chronic kidney disease through an artificial intelligence-based health coaching mobile app: retrospective cohort study. JMIR Mhealth Uhealth. 2023;11: e45531. doi: 10.2196/45531 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Fukaguchi K, Goto T, Yamamoto T, Yamagami H. Experimental implementation of NSER mobile app for efficient real-time sharing of prehospital patient information with emergency departments: interrupted time-series analysis. JMIR Form Res. 2022;6: e37301. doi: 10.2196/37301 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Kamikawa Y, Hayashi H. Predicting in-hospital mortality among non-trauma patients based on vital sign changes between prehospital and in-hospital: an observational cohort study. PLoS One. 2019;14: e0211580. doi: 10.1371/journal.pone.0211580 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Mabuchi T, Hosomi K, Yokoyama S, Takada M. Polypharmacy in elderly patients in Japan: Analysis of Japanese real‐world databases. J Clin Pharm Ther. 2020;45: 991–996. doi: 10.1111/jcpt.13122 [DOI] [PubMed] [Google Scholar]
  • 8.Cooksley T, Rose S, Holland M. A systematic approach to the unconscious patient. Clin Med (Lond). 2018;18: 88–92. doi: 10.7861/clinmedicine.18-1-88 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Lee SY, Park JH, Yoon J, Lee JY. A validation study of a deep learning-based doping drug text recognition system to ensure safe drug use among athletes. Healthcare (Basel). 2023;11: 1769. doi: 10.3390/healthcare11121769 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Seno S, Tomura S, Ono K, Akitomi S, Sekine Y, Yoshimura Y, et al. The relationship between functional outcome and prehospital time interval in patients with cerebral infarction. J Stroke Cerebrovasc Dis. 2017;26: 2800–2805. doi: 10.1016/j.jstrokecerebrovasdis.2017.06.059 [DOI] [PubMed] [Google Scholar]
  • 11.Schwartz J, Dreyer RP, Murugiah K, Ranasinghe I. Contemporary prehospital emergency medical services response times for suspected stroke in the United States. Prehosp Emerg Care. 2016;20: 560–565. doi: 10.3109/10903127.2016.1139219 [DOI] [PubMed] [Google Scholar]
  • 12.Miller GC, Britt H. A new drug classification for computer systems: The ATC extension code. Int J Bio Med Comput. 1995;40: 121–124. doi: 10.1016/0020-7101(95)01135-2 [DOI] [PubMed] [Google Scholar]
  • 13.Dizon DS, Sedrak MS, Lewis MA, Cook E, Fisch MJ, Klemp JR, et al. Incorporating digital tools to improve clinical trial infrastructure: a white paper from the digital engagement committee of SWOG. JCO Clin Cancer Inform. 2018;2: 1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Hom J, Nikowitz J, Ottesen R, Niland JC. Facilitating clinical research through automation: Combining optical character recognition with natural language processing. Clin Trials. 2022;19: 504–511. doi: 10.1177/17407745221093621 [DOI] [PubMed] [Google Scholar]
  • 15.Laique SN, Hayat U, Sarvepalli S, Vaughn B, Ibrahim M, McMichael J, et al. Application of optical character recognition with natural language processing for large-scale quality metric data extraction in colonoscopy reports. Gastrointest Endosc. 2021;93: 750–757. doi: 10.1016/j.gie.2020.08.038 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Asadullah Shaikh

27 Jul 2023

PONE-D-22-12113Development of novel optical character recognition system to reduce recording time for vital signs and prescriptions: A simulation-based studyPLOS ONE

Dear Dr. LIU,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Sep 10 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Asadullah Shaikh, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf.

2. Thank you for providing the following Funding Statement: 

“Dr. Liu reports personal fees from MERA and is the core research member of TXP Medical Co., Ltd completely outside the submitted work. Dr. Sonoo is the Chief Executive Officer of TXP Medical Co. Ltd. and reports grants from AI Hospital Research grant from Japan Cabinet Office. Dr. Goto is the Chief Scientific Officer of TXP Medical Co., Ltd.”

We note that one or more of the authors is affiliated with the funding organization, indicating the funder may have had some role in the design, data collection, analysis or preparation of your manuscript for publication; in other words, the funder played an indirect role through the participation of the co-authors.

If the funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials, please review your statements relating to the author contributions, and ensure you have specifically and accurately indicated the role(s) that these authors had in your study in the Author Contributions section of the online submission form. Please make any necessary amendments directly within this section of the online submission form.  Please also update your Funding Statement to include the following statement: “The funder provided support in the form of salaries for authors [insert relevant initials], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.”

If the funding organization did have an additional role, please state and explain that role within your Funding Statement.

Please also provide an updated Competing Interests Statement declaring this commercial affiliation along with any other relevant declarations relating to employment, consultancy, patents, products in development, or marketed products, etc. 

Within your Competing Interests Statement, please confirm that this commercial affiliation does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to  PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests). If this adherence statement is not accurate and  there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared.

3. Please amend either the abstract on the online submission form (via Edit Submission) or the abstract in the manuscript so that they are identical

Additional Editor Comments (if provided):

Dear Authors

You are hereby requested to revise the manuscript based on the comments.

Regards

Prof. Dr. Asadullah Shaikh

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: 1. The abstract mentioned gives the clear idea about the work. But it should be written in a single paragraph and these headings should be explained later in the manuscript.The abstract in the manuscript should be crisp.

2. Background study of the work should be clearly mentioned in the manuscript. It is expected the authors must add this to the paper.

3. Flow of paper is not well defined.

4. Figure 1 is about recording Flow, it is required to explain the steps in detail in content, it would be better to have a clear understanding of the workflow too.

5. Figure 1 Panel B seems of low quality. Make the figures in higher resolution and the labels can be readable.

6. Give the reference of the data used in Table 1 & 2 if it is taken from some other work or govt. data.

7. Kindly add the authentic reference of the codes of existing models taken in the manuscript.

8. Overall, the manuscript requires major revisions. There are few things to be verified by at author’s end. Like proper citation and referencing wherever the data and facts are mentioned.

9. Similarly, authors are advised to check the grammar as well as spellings. Like in line number 229 on page 12 patent is mentioned instead of patient.

10. Authors should go through journal template also.

Reviewer #2: 1. As mentioned in line no 72 "Using the iphone"; isnt the system applicable on any other smartphone other than iphone.

2.The number of participants taken for sensitivity analysis are very less. How any one can identify the appropriate results with less no of input values provided. Explain

3.Abstract should be more clear for reader's perspective.

4.Authors have provided a comparison with earlier works almost 5 years back, which cannot support this work as per the current scenario.

5.Authors should write the main contributions of the work properly. Authors have written architectural details instead of writing the main contributions.

6.Authors should take care of many typos and grammatical mistakes in the manuscript.

7.A careful proofreading is required to improve the readability of the paper.

8.Authors didn’t include any references from year 2023. An introduction is an important road map for the paper that should be consists of an opening hook to catch the researcher's attention, relevant background study, and a concrete statement that presents main argument but your introduction lacks these fundamentals, especially relevant background studies. This related work is just listed out without comparing the relationship between this paper's model and them; only the method flow is introduced at the end; and the principle of the method is not explained. To make soundness of your study must include these latest related works (years 2022-2023).

9.Mention the limitations and future works of the developed system elaborately.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: PLOS ONE Review.docx

Decision Letter 1

Asadullah Shaikh

4 Oct 2023

PONE-D-22-12113R1Development of novel optical character recognition system to reduce recording time for vital signs and prescriptions: A simulation-based studyPLOS ONE

Dear Dr. LIU,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Nov 18 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Asadullah Shaikh, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: • The article must present a scientific study that is technically competent and has evidence to back up its findings.

• Rigidly designed experiments with the right controls, replication, and sample sizes must have been used..

• The conclusions must be drawn appropriately based on the data presented.

• Authors have provided a comparison with earlier works almost 5 years back, which cannot support this work as per the current scenario.

• A careful proofreading is required to improve the readability of the paper.

• Latest References not included in the paper.

Reviewer #2: The paper is now acceptable for publication from my side as the author has done the required revision

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: review 2_Plosone.docx

Decision Letter 2

Asadullah Shaikh

11 Dec 2023

Development of novel optical character recognition system to reduce recording time for vital signs and prescriptions: A simulation-based study

PONE-D-22-12113R2

Dear Dr. LIU,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Asadullah Shaikh, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: The authors have resolved my comments.I am satisfied with the revision made by the authors.good luck

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Saurabh

Reviewer #2: No

**********

Acceptance letter

Asadullah Shaikh

9 Jan 2024

PONE-D-22-12113R2

PLOS ONE

Dear Dr. LIU,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Prof. Asadullah Shaikh

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Video. Explanatory video of the study protocol.

    (MP4)

    S2 Video. Explanatory video of the study protocol.

    (MP4)

    S1 Fig. Sample pictures of vital sign monitoring.

    Panel A. Vital signs within the normal state. Panel B. Vital signs in an abnormal state. Panel C. Vital signs in the shock state.

    (PDF)

    S2 Fig. Sample pictures of prescriptions in pharmacy notebooks.

    Prescription A (two medications; total number of characters to count for error rate calculation: 32). Prescription B (four medications; total number of characters to count for error rate calculation: 55). Prescription C (six medications; total number of characters to count for error rate calculation: 76).

    (PDF)

    S3 Fig. Recording time by profession.

    (PDF)

    S4 Fig. Recording time by Internet transmission speed (megabits per second).

    (PDF)

    S1 Table. Differences in recording time between the optical character recognition and manual typing groups (n = 38).

    (PDF)

    S2 Table. Differences in recording time by Internet transmission speed (megabits per second).

    (PDF)

    S3 Table. Differences in recording time between optical character recognition and manual typing and complete case analysis (n = 23).

    (PDF)

    Attachment

    Submitted filename: PLOS ONE Review.docx

    Attachment

    Submitted filename: Response_to_Reviewers.docx

    Attachment

    Submitted filename: review 2_Plosone.docx

    Attachment

    Submitted filename: 20231107_Response_to_Reviewers.docx

    Data Availability Statement

    Data relevant to this study are available from Dryad at https://doi.org/10.5061/dryad.fxpnvx10c.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES